Spyros Zissimopoulos

Oligomerization of the cardiac ryanodine receptor C-terminal tail.

Ryanodine receptor oligomeric interaction: identification of a putative binding region.

Interaction of FKBP12.6 with the cardiac ryanodine receptor C-terminal domain.

Central domain of the human cardiac muscle ryanodine receptor does not mediate interaction with FKBP12.6.

Ryanodine receptor interaction with the SNARE-associated protein snapin.

Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model.

Redox sensitivity of the ryanodine receptor interaction with FK506-binding protein.

FKBP12.6 binding of ryanodine receptors carrying mutations associated with arrhythmogenic cardiac disease.

Mineralocorticoid modulation of cardiac ryanodine receptor activity is associated with downregulation of FK506-binding proteins.

Disparities in the association of the ryanodine receptor and the FK506-binding proteins in mammalian heart.

N-terminus oligomerization regulates the function of cardiac ryanodine receptors.

Hax-1 identified as a two-pore channel (TPC)-binding protein.

N-terminus oligomerization is conserved in intracellular calcium release channels.

Early remodeling of perinuclear Ca2+ stores and nucleoplasmic Ca2+ signaling during the development of hypertrophy and heart failure.

Dantrolene rescues aberrant N-terminus intersubunit interactions in mutant pro-arrhythmic cardiac ryanodine receptors.

Non-ventricular, Clinical, and Functional Features of the RyR2(R420Q) Mutation Causing Catecholaminergic Polymorphic Ventricular Tachycardia.

Structural and functional interactions within ryanodine receptor.